120 related articles for article (PubMed ID: 3020039)
1. Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.
Aggarwal BB; Traquina PR; Eessalu TE
J Biol Chem; 1986 Oct; 261(29):13652-6. PubMed ID: 3020039
[TBL] [Abstract][Full Text] [Related]
2. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
Ruggiero V; Latham K; Baglioni C
J Immunol; 1987 Apr; 138(8):2711-7. PubMed ID: 3031163
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
5. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.
Rutka JT; Giblin JR; Berens ME; Bar-Shiva E; Tokuda K; McCulloch JR; Rosenblum ML; Eessalu TE; Aggarwal BB; Bodell WJ
Int J Cancer; 1988 Apr; 41(4):573-82. PubMed ID: 2833452
[TBL] [Abstract][Full Text] [Related]
6. Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.
Brekke OL; Espevik T; Bjerve KS
Lipids; 1994 Feb; 29(2):91-102. PubMed ID: 8152351
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.
Peetre C; Gullberg U; Nilsson E; Olsson I
J Clin Invest; 1986 Dec; 78(6):1694-700. PubMed ID: 3023450
[TBL] [Abstract][Full Text] [Related]
8. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
Beran M; Andersson BS; Kelleher P; Whalen K; McCredie K; Gutterman J
Blood; 1987 Mar; 69(3):721-6. PubMed ID: 3028534
[TBL] [Abstract][Full Text] [Related]
9. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
Ruggiero V; Tavernier J; Fiers W; Baglioni C
J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
[TBL] [Abstract][Full Text] [Related]
10. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.
Shalaby MR; Palladino MA; Hirabayashi SE; Eessalu TE; Lewis GD; Shepard HM; Aggarwal BB
J Leukoc Biol; 1987 Mar; 41(3):196-204. PubMed ID: 3031189
[TBL] [Abstract][Full Text] [Related]
11. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.
Aggarwal BB; Eessalu TE; Hass PE
Nature; 1985 Dec 19-1986 Jan 1; 318(6047):665-7. PubMed ID: 3001529
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol esters on down-regulation and redistribution of cell surface receptors for tumor necrosis factor-alpha.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Dec; 262(34):16450-5. PubMed ID: 2824494
[TBL] [Abstract][Full Text] [Related]
13. Differential biologic effects resulting from bimodal binding of recombinant human tumor necrosis factor to myeloid leukemia cells.
Ishikura H; Hori K; Bloch A
Blood; 1989 Feb; 73(2):419-24. PubMed ID: 2537112
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
Sugarman BJ; Aggarwal BB; Hass PE; Figari IS; Palladino MA; Shepard HM
Science; 1985 Nov; 230(4728):943-5. PubMed ID: 3933111
[TBL] [Abstract][Full Text] [Related]
15. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin.
Sherblom AP; Decker JM; Muchmore AV
J Biol Chem; 1988 Apr; 263(11):5418-24. PubMed ID: 3356692
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.
Lewis GD; Aggarwal BB; Eessalu TE; Sugarman BJ; Shepard HM
Cancer Res; 1987 Oct; 47(20):5382-5. PubMed ID: 2820567
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.
Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F
Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello CA; Cannon JG; Wolff SM; Bernheim HA; Beutler B; Cerami A; Figari IS; Palladino MA; O'Connor JV
J Exp Med; 1986 Jun; 163(6):1433-50. PubMed ID: 3486936
[TBL] [Abstract][Full Text] [Related]
19. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors.
Schoenfeld HJ; Poeschl B; Frey JR; Loetscher H; Hunziker W; Lustig A; Zulauf M
J Biol Chem; 1991 Feb; 266(6):3863-9. PubMed ID: 1847389
[TBL] [Abstract][Full Text] [Related]
20. Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteins.
Carlino JA; Lin LS; Creasey AA
J Biol Chem; 1987 Jan; 262(3):958-61. PubMed ID: 3805029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
